1. Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo;Sirotnak;Clin Cancer Res,2000
2. ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging;Zhang;Cancer Res,2007
3. Cotargeting survival signaling pathways in cancer;Grant;J Clin Invest,2007
4. Pten inactivation and the emergence of androgen-independent prostate cancer;Shen;Cancer Res,2007
5. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model;Kinkade;J Clin Invest,2008